Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer
文献类型:期刊论文
作者 | Zhu, Qiurong2,3,4; Sun, Fang3,4; Li, Tianliang3,4; Zhou, Mengxue3,4; Ye, Jiayi3,4; Ji, Aiyan3,4; Wang, Hui2; Ding, Chunyong5; Chen, Hao3,4; Xu, Zhiai1 |
刊名 | SMALL |
出版日期 | 2021-04-01 |
卷号 | 17期号:13页码:11 |
ISSN号 | 1613-6810 |
关键词 | colorectal cancer combinatory immunotherapy immunogenic cell death prodrug nanoparticles second near‐ infrared fluorescence imaging |
DOI | 10.1002/smll.202007882 |
通讯作者 | Wang, Hui(cewangh@imu.edu.cn) ; Ding, Chunyong(chunding@sjtu.edu.cn) ; Xu, Zhiai(zaxu@chem.ecnu.edu.cn) |
英文摘要 | Colorectal cancer (CRC) ranks as the third common and the fourth lethal cancer type worldwide. Immune checkpoint blockade therapy demonstrates great efficacy in a subset of metastatic CRC patients, but precise activation of the antitumor immune response at the tumor site is still challenging. Here a versatile prodrug nanoparticle for second near-infrared (NIR-II) fluorescence imaging-guided combinatory immunotherapy of CRC is reported. The prodrug nanoparticles are constructed with a polymeric oxaliplatin prodrug (PBOXA) and a donor-spacer-acceptor-spacer-donor type small molecular fluorophore TQTCD. The later displays large Stokes shift (>300 nm), fluorescence emission over 1000 nm, and excellent photothermal conversion performance for NIR-II fluorescence imaging-guided photothermal therapy (PTT). The prodrug nanoparticles show seven times higher intratumoral OXA accumulation than free oxaliplatin. TQTCD-based PTT and PBOXA-induced chemotherapy trigger immunogenic cell death of the tumor cells and elicit antitumor immune response in a spatiotemporally controllable manner. Further combination of the prodrug nanoparticle-based PTT/chemotherapy with programmed death ligand 1 blockade significantly promotes intratumoral infiltration of the cytotoxic T lymphocytes and eradicates the CRC tumors. The NIR-II fluorescence imaging-guided immunotherapy may provide a promising approach for CRC treatment. |
资助项目 | National Natural Science Foundation of China[51873228] ; National Natural Science Foundation of China[22074043] ; International Cooperation Project of Science and Technology Commission of Shanghai Municipality[20430711800] ; Youth Innovation Promotion Association of CAS[2014218] ; China Postdoctoral Science Foundation[2019M661667] ; China Postdoctoral Science Foundation[2020M681429] ; Shanghai Post-Doctoral Excellence Program ; Shanghai Institute of Materia Medica, CAS[FU-SIMM-20182006] ; State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, CAS ; Fudan University[FU-SIMM-20182006] |
WOS研究方向 | Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics |
语种 | 英语 |
出版者 | WILEY-V C H VERLAG GMBH |
WOS记录号 | WOS:000627071800001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/295692] |
专题 | 新药研究国家重点实验室 |
通讯作者 | Wang, Hui; Ding, Chunyong; Xu, Zhiai |
作者单位 | 1.East China Normal Univ, Sch Chem & Mol Engn, Shanghai 200241, Peoples R China 2.Inner Mongolia Univ, Coll Chem & Chem Engn, Hohhot 010021, Peoples R China 3.Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, 501 Haike Rd, Shanghai 201203, Peoples R China 4.Chinese Acad Sci, Ctr Pharmaceut, Shanghai Inst Mat Med, 501 Haike Rd, Shanghai 201203, Peoples R China 5.Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200241, Peoples R China |
推荐引用方式 GB/T 7714 | Zhu, Qiurong,Sun, Fang,Li, Tianliang,et al. Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer[J]. SMALL,2021,17(13):11. |
APA | Zhu, Qiurong.,Sun, Fang.,Li, Tianliang.,Zhou, Mengxue.,Ye, Jiayi.,...&Yu, Haijun.(2021).Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer.SMALL,17(13),11. |
MLA | Zhu, Qiurong,et al."Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer".SMALL 17.13(2021):11. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。